Form 4 for TER Teradyne
Accepted 2026-05-26 17:23:39 ET · period of report 2026-05-21 · accession 0000904454-26-000321 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-05-26 17:23 | 2026-05-21+ | TER | Poulin Shannon John | Pres, Semiconductor Test | S - Sale+OE | $349.17 | -1,664 | 15.7K | -10% | -$581.0K |
| DT | 2026-05-26 17:23 | 2026-05-21 | TER | Poulin Shannon John | Pres, Semiconductor Test | M - OptEx | $82.61 | +2,843 | 17.9K | +19% | +$234.9K |
| DT | 2026-05-26 17:23 | 2026-05-21 | TER | Poulin Shannon John | Pres, Semiconductor Test | F - Tax | $345.98 | -1,531 | 16.4K | -9% | -$529.7K |
| DT | 2026-05-26 17:23 | 2026-05-21 | TER | Poulin Shannon John | Pres, Semiconductor Test | M - OptEx | $0.00 | -2,843 | 8,532 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-21 | S | D | 1,008 | $345.37 | 15,065.58 | D | — | — | (F1) The reported transactions were effected pursuant to a sales plan adopted by the Reporting Person on February 19, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. |
| 2 | Common | Common Stock | 2026-05-21 | M | A | 2,843 | $82.61 | 17,908.58 | D | — | — | (F1) The reported transactions were effected pursuant to a sales plan adopted by the Reporting Person on February 19, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. |
| 3 | Common | Common Stock | 2026-05-21 | F | D | 1,531 | $345.98 | 16,377.58 | D | — | — | (F2) Shares withheld by the Issuer to pay the exercise price of the stock option exercise reported in this Form 4 and to satisfy the Reporting Person's tax withholding obligations in connection with such exercise. (F2) Shares withheld by the Issuer to pay the exercise price of the stock option exercise reported in this Form 4 and to satisfy the Reporting Person's tax withholding obligations in connection with such exercise. |
| 4 | Common | Common Stock | 2026-05-22 | S | D | 656 | $355.00 | 15,721.58 | D | — | — | (F1) The reported transactions were effected pursuant to a sales plan adopted by the Reporting Person on February 19, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-05-21 | M | D | 2,843 | $0.00 | 8,532 | D | $82.61 · — to 2032-04-01 | 2,843 Common Stock | (F1) The reported transactions were effected pursuant to a sales plan adopted by the Reporting Person on February 19, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. (F3) This option was granted under the Issuer's 2006 Equity and Cash Compensation Incentive Plan, and vests at the rate of 25% per year beginning on April 1, 2026, the first anniversary of the grant. |